Carl-Hendrik Heldin

Carl-Hendrik Heldin

Presidente en
European Molecular Biology Organization
.
72 años
Miscellaneous
Consumer Services
Health Technology

Perfil

Carl-Hendrik Heldin is the founder of Mesenkia Therapeutics AB. Current jobs include Chairman at the European Molecular Biology Organization since 2016, Chairman at Science for Life Laboratory since 2013, and Professor at the University of Uppsala since 1992.
Former jobs include Chairman at The Nobel Foundation from 2013 to 2024, Director at Ludwig Institute for Cancer Research Ltd. (Sweden) from 1986 to 2017, Independent Director at Kancera AB from 2012 to 2025, and Vice President at the European Research Council.

Cargos activos de Carl-Hendrik Heldin

EmpresasCargoInicio
Corporate Officer/Principal 01/01/1992
Presidente 01/01/2013
European Molecular Biology Organization
Presidente 01/01/2016

Antiguos cargos conocidos de Carl-Hendrik Heldin.

EmpresasCargoFin
KANCERA AB Director/Miembro de la Junta 26/05/2025
Presidente 02/12/2024
Ludwig Institute for Cancer Research Ltd. (Sweden)
Director/Miembro de la Junta 01/01/2017
Corporate Officer/Principal 01/01/2014
Ver el detalle de la experiencia de Carl-Hendrik Heldin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

87

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Consumer Services

Miscellaneous

European Molecular Biology Organization

Miscellaneous

Health Technology

Ludwig Institute for Cancer Research Ltd. (Sweden)

Commercial Services

  1. Bolsa de valores
  2. Insiders
  3. Carl-Hendrik Heldin
40% de descuento. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN